# Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate

> **NCT06479330** · NA · COMPLETED · sponsor: **Mondelēz International, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Gastrointestinal Tolerance
- Healthy Population

## Interventions

- **OTHER:** Milk Chocolate

## Key facts

- **NCT ID:** NCT06479330
- **Lead sponsor:** Mondelēz International, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-09
- **Primary completion:** 2024-10-16
- **Final completion:** 2024-12-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479330, "Evaluating the Impact of Incremental Doses of a Sugar Replacer Blend on Gastrointestinal Tolerance in Chocolate". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06479330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*